| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |